Changping District Places High Emphasis on Incubation Platform Construction, Creating a Favorable Business Environment for Small and Medium-sized Enterprises. In the Future Science City's 'Life Valley,' a complete industry chain and innovation chain encompassing basic research, pilot research and development, production and distribution, and terminal healthcare have been formed. The gathering effect of the pharmaceutical and healthcare industry is becoming increasingly prominent, accelerating industrial development.
Dart Incubator focuses on serving and meeting the common needs of research and innovation companies in fields such as drug development, gene editing, and vaccine research. Leveraging its internationalized laboratory environment and specialized research-sharing platform, it provides 'move-in ready' services for innovative projects. DiNaYuanSheng (Beijing) Biotechnology Co., Ltd. is a biopharmaceutical company dedicated to creating a new platform for small nucleic acid drug delivery. Within the Dart Incubator, companies only need to submit an experiment application to use shared laboratories, significantly reducing their research and development costs.
As of the end of July, Dart Incubator has helped over 20 biomedical innovation teams accelerate their development, with a total financing amount exceeding 2 billion RMB. In August of this year, Dart Incubator Phase II officially commenced operations, establishing a genomics sequencing center and a proteomics testing center, further enriching the diverse innovation ecosystem.
Enterprise incubation not only requires a top-notch platform but also a top-notch business environment. In July of this year, the 'Changsheng Station' administrative service scene at the Zhongguancun Life Science Park officially started its operations. It offers a one-stop service for more than 137 service items involving over 10 departments, including market regulation, tax, and health services, for park-based companies. Utilizing 5G video communication technology, it has pioneered the 'remote approval' service model in the city's industrial parks, making it more convenient for business personnel to handle affairs
Having the right capabilities makes a place attractive. The Zhongguancun Life Science Park has gathered over 600 innovative pharmaceutical companies and has attracted heavyweight research institutions like the Beijing Institute of Life Sciences and the National Protein Science Center (Beijing Base). It has established professional platforms such as AI drug development and the Beijing Bio-Specimen Library. Additionally, it has clinical resources like Peking University International Hospital and the first research-oriented hospital, Gaobo Hospital. These efforts have formed an ecosystem that spans basic research, pilot research and development, production and distribution, and terminal healthcare, attracting hundreds of biomedical startups and teams to settle in the Life Science Park.
